The cardiovascular manifestations of Alagille syndrome and JAGI mutations
Related Experiment Video
Updated: Jul 20, 2026

Determining Bile Duct Density in the Mouse Liver
Published on: April 30, 2019
Elizabeth Goldmuntz1, Elizabeth Moore, Nancy B Spinner
1The Division of Cardiology, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Abstract:
Alagille syndrome is an autosomal-dominant disorder characterized by hepatic, cardiac, ocular, skeletal, and facial abnormalities. The disease gene, Jaggedl (JAG]), was identified by molecular analyses of chromosomal alterations involving chromosome 20p. Total gene deletions (3-7%) and intragenic mutations (70%) of JAG] have been identified in Alagille patients. Identifying JAG] mutations is challenging, given its size of 26 exons. Methods to identify both whole-gene deletions and intragenic mutations of JAG] are described in detail, including fluorescence in situ hybridization (FISH), conformation-sensitive gel electrophoresis (CSGE), and complementary DNA (cDNA) sequencing.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

